NO992005D0 - New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes - Google Patents
New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromesInfo
- Publication number
- NO992005D0 NO992005D0 NO992005A NO992005A NO992005D0 NO 992005 D0 NO992005 D0 NO 992005D0 NO 992005 A NO992005 A NO 992005A NO 992005 A NO992005 A NO 992005A NO 992005 D0 NO992005 D0 NO 992005D0
- Authority
- NO
- Norway
- Prior art keywords
- syndromes
- estrogen
- prevention
- treatment
- related diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK119996 | 1996-10-28 | ||
PCT/DK1997/000485 WO1998018778A1 (en) | 1996-10-28 | 1997-10-28 | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992005D0 true NO992005D0 (en) | 1999-04-27 |
NO992005L NO992005L (en) | 1999-06-25 |
Family
ID=8102089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992005A NO992005L (en) | 1996-10-28 | 1999-04-27 | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0934299A1 (en) |
JP (1) | JP2001502710A (en) |
AU (1) | AU4772297A (en) |
CA (1) | CA2270056A1 (en) |
IL (1) | IL129618A0 (en) |
NO (1) | NO992005L (en) |
WO (1) | WO1998018778A1 (en) |
ZA (1) | ZA979649B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153768A (en) * | 1996-12-13 | 2000-11-28 | C & C Research Laboratories | Benzopyran derivatives |
JP2000119187A (en) * | 1998-10-15 | 2000-04-25 | Taisho Pharmaceut Co Ltd | Composition for preventing or improving depressed mood |
MX2007003216A (en) | 2004-09-21 | 2008-03-10 | Novogen Res Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy. |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
US9708283B2 (en) | 2010-11-01 | 2017-07-18 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
WO2016126618A1 (en) | 2015-02-02 | 2016-08-11 | Mei Pharma, Inc. | Combination therapies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1543749A1 (en) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Process for the preparation of 3,4-cis-4-aryl-isoflavans |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 CA CA002270056A patent/CA2270056A1/en not_active Abandoned
- 1997-10-28 AU AU47722/97A patent/AU4772297A/en not_active Abandoned
- 1997-10-28 WO PCT/DK1997/000485 patent/WO1998018778A1/en not_active Application Discontinuation
- 1997-10-28 ZA ZA9709649A patent/ZA979649B/en unknown
- 1997-10-28 IL IL12961897A patent/IL129618A0/en unknown
- 1997-10-28 JP JP10519944A patent/JP2001502710A/en active Pending
- 1997-10-28 EP EP97910266A patent/EP0934299A1/en not_active Withdrawn
-
1999
- 1999-04-27 NO NO992005A patent/NO992005L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL129618A0 (en) | 2000-02-29 |
NO992005L (en) | 1999-06-25 |
CA2270056A1 (en) | 1998-05-07 |
ZA979649B (en) | 1998-04-28 |
AU4772297A (en) | 1998-05-22 |
EP0934299A1 (en) | 1999-08-11 |
JP2001502710A (en) | 2001-02-27 |
WO1998018778A1 (en) | 1998-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID18925A (en) | THE USE OF SUBSTITUTED BENZAZOLS AS UV ABSORBENS, NEW BENZAZOLS AND PROCESSES FOR THE PRODUCTION | |
NO944857D0 (en) | Fluorenyl-containing metallocenes, process for their preparation and process for polymerization of olefins using the metallocenes | |
NO954942D0 (en) | New erythromycin derivatives, processes for their preparation and use of the derivatives as drugs | |
NO992641D0 (en) | Mixtures and Methods for the Treatment or Prevention of Inflammatory Diseases | |
ATE376994T1 (en) | ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOVASCULAR DISEASES | |
NL1001338C2 (en) | 2-Hydroxyphenyltriazines, process for their preparation and use of UV absorbers. | |
TR199500952A2 (en) | New n-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect. | |
NO20005143D0 (en) | Methods and compositions for delaying the crosslinking of crosslinkable polysaccharide based materials lost through circulation | |
NO864241L (en) | PROCEDURE FOR BLACKING CELLULOSMASS OR FRAGMENT THEREOF, PLANT FOR USE BY IMPLEMENTATION OF THE PROCEDURE AND SCREW PRESSURE, SPECIFICALLY FOR USE BY THE PROCEDURE UNDER THE APPLICATION. | |
NO911956L (en) | PROCEDURE FOR THE PREPARATION OF OXYDANT SENSITIVE AND INSENSITIVE, AROMATIC ESTERS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS | |
NO992010D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO983261D0 (en) | New Benzoylguanidine Derivatives, Methods of Preparing Them and Using Them in the Preparation of Medicines | |
NO995723L (en) | New triptolide derivatives useful in the treatment of autoimmune diseases | |
NO992009D0 (en) | New trans-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992008D0 (en) | New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992005D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992003D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992002D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO995722L (en) | New triptolide derivatives useful in the treatment of autoimmune diseases | |
NO953989D0 (en) | New polycyclic systems and derivatives thereof, such as neurotransmitter release-seeking agents useful in the treatment of cognitive disorders | |
IT1278056B1 (en) | DERIVATIVES OF S-TRIAZINE, THEIR PREPARATION AND THEIR USE AS UV ABSORBENTS. | |
NO992004D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992006D0 (en) | New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO992007L (en) | Novel (-) Enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes | |
NO985535D0 (en) | Process for the preparation of 1,3-alkanediols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |